Jaka jest cena za IAnthus Capital Holdings, Inc. (IAN)

Cena za IAnthus Capital Holdings, Inc. (IAN) wynosi $0.00366968

Jaka jest kapitalizacja rynkowa dla IAnthus Capital Holdings, Inc. (IAN)

Kapitalizacja rynkowa dla IAnthus Capital Holdings, Inc. (IAN) wynosi $25.59M

Przychody IAnthus Capital Holdings, Inc. (IAN)

iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.

Rok	Przychody	Zmień
Za mało danych dla podanych dat.

Rok

Przychody

Zmień

Za mało danych dla podanych dat.

Firma	Przychody	Różnica w przychodach	Kraj
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Firma

Przychody

Różnica w przychodach

Kraj